Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Albers

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Digestive Diseases and Sciences|June 11, 2020
Oral IBGard™ Before Colonoscopy: A Single-Center Double-Blinded, Randomized, Placebo-Controlled TrialJames Y Han, Zain Moosvi, Erica Duh, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2017
Biomarkers for severe eosinophilic asthmaSteven W Yancey, Oliver N Keene, Frank C Albers, et al.
Allergy|April 19, 2016
Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatmentA Magnan, A Bourdin, C M Prazma, et al.
Respiratory Research|May 5, 2019
Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysisCharlene M Prazma, Elisabeth H Bel, Robert G Price, et al.
The Clinical Respiratory Journal|January 26, 2022
Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthmaFrank C Albers, Daniel J Bratton, Necdet B Gunsoy, et al.
The American Journal of Medical Technology|November 1, 1983
Selective pigment medium for Streptococcus agalactiaeA C Albers, J M Sniffen, D N Freedel, et al.
Physical Review Letters|February 1, 2008
Reversal of spin polarization in Fe/GaAs (001) driven by resonant surface states: first-principles calculationsAthanasios N Chantis, Kirill D Belashchenko, Darryl L Smith, et al.
Journal of Asthma and Allergy|June 24, 2021
Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic PhenotypesCharlene M Prazma, Marco Idzko, Jo Anne Douglass, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 29, 2019
Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational studyLinda M Nelsen, Sarah M Cockle, Necdet B Gunsoy, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Digestive Diseases and Sciences|June 11, 2020
Oral IBGard™ Before Colonoscopy: A Single-Center Double-Blinded, Randomized, Placebo-Controlled TrialJames Y Han, Zain Moosvi, Erica Duh, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2017
Biomarkers for severe eosinophilic asthmaSteven W Yancey, Oliver N Keene, Frank C Albers, et al.
Allergy|April 19, 2016
Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatmentA Magnan, A Bourdin, C M Prazma, et al.
Respiratory Research|May 5, 2019
Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysisCharlene M Prazma, Elisabeth H Bel, Robert G Price, et al.
The Clinical Respiratory Journal|January 26, 2022
Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthmaFrank C Albers, Daniel J Bratton, Necdet B Gunsoy, et al.
The American Journal of Medical Technology|November 1, 1983
Selective pigment medium for Streptococcus agalactiaeA C Albers, J M Sniffen, D N Freedel, et al.
Physical Review Letters|February 1, 2008
Reversal of spin polarization in Fe/GaAs (001) driven by resonant surface states: first-principles calculationsAthanasios N Chantis, Kirill D Belashchenko, Darryl L Smith, et al.
Journal of Asthma and Allergy|June 24, 2021
Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic PhenotypesCharlene M Prazma, Marco Idzko, Jo Anne Douglass, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 29, 2019
Impact of exacerbations on St George's Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational studyLinda M Nelsen, Sarah M Cockle, Necdet B Gunsoy, et al.
Pageof 13